Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BOLT Bolt Biotherapeutics	$6.22 +3.0%	$6.31	$5.20 ▼ $15.60	$11.92M	0.89	11,487 shs	9,167 shs
CZX Canada Zinc Metals	C$0.31 +∞	C$0.31	C$0.22 ▼ C$0.39	C$51.69M	N/A	238,645 shs	118,500 shs
FCR First Capital Realty		C$0.00	C$18.60 ▼ C$22.79	N/A	N/A	468,009 shs	3.04 million shs
ION ProShares S&P Global Core Battery Metals ETF	$29.86 -0.4%	$27.72	$20.72 ▼ $32.38	$2.24M	1.66	1,433 shs	463 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BOLT Bolt Biotherapeutics	+2.90%	+0.67%	-6.50%	-10.91%	-58.91%
CZX Canada Zinc Metals	0.00%	0.00%	0.00%	0.00%	0.00%
FCR First Capital Realty	0.00%	0.00%	0.00%	0.00%	0.00%
ION ProShares S&P Global Core Battery Metals ETF	+1.49%	+2.15%	+5.19%	+29.80%	+6.84%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BOLT Bolt Biotherapeutics	2.9726 of 5 stars	3.2	3.0	0.0	0.0	2.8	1.7	1.3
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ION ProShares S&P Global Core Battery Metals ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BOLT Bolt Biotherapeutics	2.33	Hold	$50.00	703.86% Upside
CZX Canada Zinc Metals	0.00	N/A	N/A	N/A
FCR First Capital Realty	4.00	Strong Buy	N/A	N/A
ION ProShares S&P Global Core Battery Metals ETF	2.33	Hold	$29.86	N/A

Current Analyst Ratings Breakdown

Latest ION, BOLT, CZX, and FCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/20/2025	BOLT Bolt Biotherapeutics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$80.00
5/13/2025	BOLT Bolt Biotherapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$25.00 ➝ $20.00

(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BOLT Bolt Biotherapeutics	$3.64M	3.28	N/A	N/A	$29.89 per share	0.21
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A	N/A
ION ProShares S&P Global Core Battery Metals ETF	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BOLT Bolt Biotherapeutics	-$63.12M	-$33.40	N/A	N/A	N/A	N/A	-94.51%	-59.07%	8/12/2025 (Estimated)
CZX Canada Zinc Metals	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
ION ProShares S&P Global Core Battery Metals ETF	N/A	N/A	16.75	∞	N/A	N/A	N/A	N/A	N/A

Latest ION, BOLT, CZX, and FCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/12/2025	Q1 2025	BOLT Bolt Biotherapeutics	-$6.80	-$5.80	+$1.00	-$0.29	$0.77 million	$1.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BOLT Bolt Biotherapeutics	$0.36	5.79%	N/A	N/A	N/A
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A
ION ProShares S&P Global Core Battery Metals ETF	$0.51	1.71%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BOLT Bolt Biotherapeutics	0.48	3.13	3.13
CZX Canada Zinc Metals	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A
ION ProShares S&P Global Core Battery Metals ETF	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BOLT Bolt Biotherapeutics	86.70%
CZX Canada Zinc Metals	N/A
FCR First Capital Realty	N/A
ION ProShares S&P Global Core Battery Metals ETF	N/A

Insider Ownership

Company	Insider Ownership
BOLT Bolt Biotherapeutics	6.10%
CZX Canada Zinc Metals	N/A
FCR First Capital Realty	N/A
ION ProShares S&P Global Core Battery Metals ETF	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BOLT Bolt Biotherapeutics	90	1.92 million	1.33 million	Not Optionable
CZX Canada Zinc Metals	147,000	166.73 million	N/A	Not Optionable
FCR First Capital Realty	N/A	N/A	N/A	Not Optionable
ION ProShares S&P Global Core Battery Metals ETF	N/A	75,000	N/A	Not Optionable

ION, BOLT, CZX, and FCR Headlines

Recent News About These Companies

ION Announces Closing of Debt Settlement and Update on Joint Venture on Urgakh Naran Project

July 3, 2025 | newsfilecorp.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
3 Semiconductor Stocks Poised to Surge on AI Spending
By Chris Markoch | June 25, 2025
View 3 Semiconductor Stocks Poised to Surge on AI Spending
How a Government Loan Changes the Game for Plug Power
By Jeffrey Neal Johnson | July 4, 2025
View How a Government Loan Changes the Game for Plug Power
3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated
By Jeffrey Neal Johnson | June 18, 2025
View 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated

ION, BOLT, CZX, and FCR Company Descriptions

Bolt Biotherapeutics NASDAQ:BOLT

$6.22 +0.18 (+2.98%)

Closing price 04:00 PM Eastern

Extended Trading

$6.22 0.00 (-0.08%)

As of 05:35 PM Eastern

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals CVE:CZX

C$0.31 +0.31 (+∞)

As of 05/4/2018

Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.

First Capital Realty TSE:FCR

ProShares S&P Global Core Battery Metals ETF NYSEARCA:ION

$29.86 -0.11 (-0.37%)

As of 04:10 PM Eastern

The Proshares S&P Global Core Battery Metals ETF (ION) is an exchange-traded fund that is based on the S&P Global Core Battery Metals index. The fund tracks an index of companies from around the world that are engaged in the mining of base metals used to produce batteries. ION was launched on Nov 29, 2022 and is managed by ProShares.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time